NCT07440290: DETERMINE Trial Treatment Arm 07: Dabrafenib in Combination With Trametinib in Adult, Paediatric and Teenage/Young Adult Patients With BRAF V600 Mutation-Positive Cancers.
- State
- Under way
- Phase
- Phase 2 and Phase 3
- People
- 30 planned
- Started
- 1 Apr 2026
- Primary completion
- Oct 2029
- Arms
- Treatment Arm 07: Dabrafenib and Trametinib
- Results
- None posted
- 27 Feb 2026: Trial registered
- 1 Apr 2026: Trial started